Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Iron vs Conventional Oral Iron in Iron Deficiency Anemia After Sleeve Gastrectomy
NCT07366502Completed
- Sponsor
- Medeni Şermet
- Start
- Sep 2025
- Primary completion
- May 2026
- Modality
- Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Randomised trial of ferric pyrophosphate liposomal in iron deficiency anemia (IDA) (2 arms), sponsored by Medeni Şermet. Primary endpoint: Change in Hemoglobin at 24 weeks. Started Sep 2025; status: completed.
02
Drugs
ferric pyrophosphate liposomal
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT07366502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07366502.